Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current assets
Cash and cash equivalents	$ 130,104	$ 57,526
Marketable securities	137,765	177,161
Accounts receivable	18,192	20,473
Prepaid expenses	11,094	9,067
Other current assets	16,082	13,774
Total current assets	313,237	278,001
Marketable securities	4,858	10,179
Accounts receivable	1,208	474
Property and equipment, net	114,497	117,589
Operating lease right-of-use assets	52,112	53,716
Restricted cash	2,030	2,030
Other assets	2,987	4,000
Total assets	490,929	465,989
Current liabilities
Accounts payable	19,044	22,798
Accrued expenses and other current liabilities	23,597	38,070
Deferred revenue	13,588	115
Operating lease liabilities	7,942	7,902
Liability related to sale of future royalties	42,560	34,309
Total current liabilities	106,731	103,194
Deferred revenue	26,297
Operating lease liabilities	71,906	74,131
Liability related to sale of future royalties	11,118	25,378
Other liabilities	680	3,635
Total liabilities	216,732	206,338
Stockholders’ equity
Preferred stock; $0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at March 31, 2025 and December 31, 2024
Common stock; $0.0001 par value; 100,000 shares authorized at March 31, 2025 and December 31, 2024; 50,117 and 49,549 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively	5	5
Additional paid-in capital	1,201,020	1,192,536
Accumulated other comprehensive loss	(762)	(741)
Accumulated deficit	(926,066)	(932,149)
Total stockholders’ equity	274,197	259,651
Total liabilities and stockholders’ equity	$ 490,929	$ 465,989